Gufic BioSciences Share Price

NSE
345.15
-10.60 (2.86%)
GUFICBIO • 23 Jun, 2025 | 03:29 PM
BUY

1Y Annualised Return

-0.74%

3Y Annualised Return

15.26%

5Y Annualised Return

34.85%

The current prices are delayed, login or Open Demat Account for live prices.

Gufic BioSciences SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹64,75,916 (-0.37%)

Daily SIP of 25,000 would have become 64,75,916 in 1 year with a gain of -24,083 (-0.37%)

Gufic BioSciences Stock Performance
Today’s Low - High
345.00
357.20
345.00
357.20
52 Week Low - High
298.80
504.25
298.80
504.25

Open

355.00

Prev. Close

355.75

Total Traded Value

1.16 Cr

View details of Market Depth
Gufic BioSciences Fundamental

Market Cap (in crs)

3,472.61

Face Value

1

Turnover (in lacs)

116.44

Key Metrics
Qtr Change %
31.32% Fall from 52W High
1.8
Dividend yield 1yr %
0.03

Gufic BioSciences Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Gufic BioSciences Quarterly Revenue

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
205.02 Cr
207.79 Cr
204.18 Cr
202.81 Cr
194.99 Cr

Gufic BioSciences Yearly Revenue

Mar 2025Mar 2024
823.43 Cr
808.84 Cr

Gufic BioSciences Quarterly Net Profit/Loss

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
7.72 Cr
19.31 Cr
21.77 Cr
20.86 Cr
20.05 Cr

Gufic BioSciences Yearly Net Profit/Loss

Mar 2025Mar 2024
69.65 Cr
86.14 Cr
Gufic BioSciences Result Highlights
  • Gufic BioSciences Ltd reported a 6.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.

  • Its expenses for the quarter were down by 8.0% QoQ and - - YoY.

  • The net profit increased 3.8% QoQ and - - YoY.

  • The earnings per share (EPS) of Gufic BioSciences Ltd stood at 2 during Q4FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Gufic BioSciences shareholding Pattern

Promoter
72.5%
Foreign Institutions
0.3%
Mutual Funds
3.4%
Domestic Institutions
3.4%
Public
23.8%
Promoter
72.5%
Foreign Institutions
0.3%
Mutual Funds
2.9%
Domestic Institutions
3%
Public
24.2%
Promoter
72.5%
Foreign Institutions
0.2%
Mutual Funds
2.5%
Domestic Institutions
2.5%
Public
24.8%
Promoter
72.5%
Foreign Institutions
0.2%
Mutual Funds
2.3%
Domestic Institutions
2.4%
Public
24.9%
Promoter
72.5%
Foreign Institutions
0.1%
Mutual Funds
2.1%
Domestic Institutions
2.2%
Public
25.2%
Promoter
72.5%
Foreign Institutions
0.5%
Mutual Funds
1.6%
Domestic Institutions
1.7%
Public
25.3%

Gufic BioSciences Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
345.15
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
356.70
10Day EMA
362.30
12Day EMA
363.70
20Day EMA
366.80
26Day EMA
367.50
50Day EMA
368.20
100Day EMA
374.60
200Day EMA
377.50
5Day SMA
358.80
10Day SMA
365.40
20Day SMA
370.70
30Day SMA
373.60
50Day SMA
366.70
100Day SMA
368.80
150Day SMA
393.50
200Day SMA
399.00
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
17545 Rs
37506 Rs
Week Rs
17122 Rs
32875 Rs
Month Rs
26379 Rs
49471 Rs
Resistance & Support
349.50
Pivot
Resistance
First Resistance
354
Second Resistance
361.70
Third Resistance
366.20
Support
First Support
341.80
Second support
337.30
Third Support
329.60
Relative Strength Index
32.12
Money Flow Index
51.97
MACD
-3.76
MACD Signal
-0.64
Average True Range
12.48
Average Directional Index
17.80
Rate of Change (21)
-8.63
Rate of Change (125)
-21.64
Shareholding
Name
Holding Percent
Motilal Oswal Small Cap Fund
1.38

Gufic BioSciences Latest News

06 JUN 2025 | Friday

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

02 JUN 2025 | Monday

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

31 MAY 2025 | Saturday

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication

View More

Gufic BioSciences Company background

Founded in: 1984
Managing director: Jayesh P Choksi
Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients. Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network. The Company is ranked among the top 100 pharmaceutical companies in India.Gufic is a leading manufacturer of lyophilized injections in India, with a stateoftheart automated lyophilization plant located in Navsari, Gujarat. The Company was incorporated in July, 1984. The recent addition of the Indore manufacturing facility has further solidified Gufics position as one of the worlds largest producers of lyophilized injections. These products cover therapeutic areas, including antibiotics, antifungals, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs).The Company made a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 4042 per share and then got GBL listed on BSE. Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Choksi and Gandhi family, the promoters of GBL, have a longstanding presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals, the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently, the overall profile of GBL comprises ethical products, herbal products, consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years, the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins), Onergy, and Stretch nil.In the year 2000, the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held.Gufic has divested brands in the ethical pharma business in a sellers market. The company plan to invest further in RD activities and aggressively enter the herbal product and consumer product segments, where it foresee a huge potential. While benefiting from the rich, traditional knowledge base in India, it would like to operate from an area of strength in the herbal products segment.In 202021, Gufic Lifesciences Private Limited amalgamated with the Company through the Scheme of Amalgamation which became effective from May 21, 2021. GUFIC UK LIMITED (GUL), a wholly owned subsidiary of the Company, was incorporated in United Kingdom on March 15, 2022. Similarly, in 2023, Gufic Ireland Limited (GIL) was incorporated on March 02, 2023.

As of 23 Jun, 2025, Gufic BioSciences share price is ₹346.3. The stock opened at ₹355 and had closed at ₹355.8 the previous day. During today’s trading session, Gufic BioSciences share price moved between ₹345.00 and ₹357.20, with an average price for the day of ₹351.10. Over the last 52 weeks, the stock has recorded a low of ₹298.80 and a high of ₹504.25. In terms of performance, Gufic BioSciences share price has declined by 19.9% over the past six months and has declined by 0.74% over the last year.

Read More

Gufic BioSciences FAQs

Gufic BioSciences share price is ₹345.15 in NSE and ₹348.8 in BSE as on 23/6/2025.

Gufic BioSciences share price in the past 1-year return was -3.8. The Gufic BioSciences share hit a 1-year low of Rs. 298.8 and a 1-year high of Rs. 504.25.

The market cap of Gufic BioSciences is Rs. 3472.61 Cr. as of 23/6/2025.

The PE ratios of Gufic BioSciences is 49.73 as of 23/6/2025.

The PB ratios of Gufic BioSciences is 5.78 as of 23/6/2025

The Mutual Fund Shareholding in Gufic BioSciences was 3.39% at the end of 23/6/2025.

You can easily buy Gufic BioSciences shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Gufic BioSciences stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -